ReviewTherapeutic advances in medical oncology2021

Oncogenic mechanism-based pharmaceutical validation of therapeutics targeting MET receptor tyrosine kinase.

Hang-Ping Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.